Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-27

FDA Approved: FESOTERODINE FUMARATE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for fesoterodine fumarate from Aurobindo Pharma Limited, a generic treatment for overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fesoterodine fumarate (fesoterodine fumarate)

Snippet

SUPPL AP for FESOTERODINE FUMARATE (FESOTERODINE FUMARATE)